Tau protein is a critical pathological biomarker for Alzheimer’s disease (AD) and other neurodegenerative disorders, playing a pivotal role in early diagnosis, monitoring disease progression, and evaluating therapeutic efficacy [128,129]. The gene discussed is MAPT; the disease is Alzheimer disease.